La Universitat de Girona té més de 15.000 estudiants i 1.400 professors. Ofereix uns 50 estudis de grau i més de 20 màsters. S’organitza en 9 centres docents, 1 Escola de Doctorat, 6 centres adscrits. L’activitat de recerca es du a terme en 24 departaments, 12 instituts de recerca i més de 40 càtedres, a més d’un centenar de grups de recerca especialitzat. Té la seu a la ciutat de Girona i s’integra en el sistema d’universitats públiques catalanes.
També trobareu les tesis recol·lectades al repositori DUGi .
Si sou doctor o doctora de la Universitat de Girona i voleu publicar la vostra tesi a TDX, contacteu amb tdx@udg.edu. Per a més informació consulteu les preguntes més freqüents.
Vilà-Quintana, Laura (Data de defensa: 2025-02-07)
ENG- Pancreatic cancer (PDAC) is becoming more common, especially in developed countries, due to risk factors like smoking and alcohol-related chronic pancreatitis (CP). Its hidden location often causes late-stage diagnosis, ...
Romera Martínez, Ingrid (Data de defensa: 2024-12-05)
ENG- The radiotherapy treatment for left breast cancer is widely described. One of the long-term undesirable effects of radiotherapy is heart disease, which often manifests as ischemia or myocardial infarction, especially ...
Casellas-Vidal, Dolors (Data de defensa: 2024-11-27)
ENG- Introduction: Children with spastic cerebral palsy (CP) suffer from biomechanical changes in their muscles, causing excessive spasticity. These changes in muscle tone can be estimated by means of clinical scales or ...
Sojo Vega, Lidia (Data de defensa: 2024-12-02)
ENG- Cardiovascular diseases (CVDs) are the leading cause of death and illness in people with type 1 diabetes (T1D). However, the traditional prediction models for cardiovascular events, which are based on common risk ...
Pla-Juher, Helena (Data de defensa: 2024-12-02)
ENG- HER2 positive breast cancer represents approximately 15-20% of breast cancer and it is associated with higher grade, more aggressive phenotype and worse prognosis. The prognosis of these patients has dramatically ...
Lluch Balaña, Aina (Data de defensa: 2024-10-22)
ENG- Obesity is a complex chronic disease linked to adipocyte dysfunction and a low-grade inflammatory condition leading to the impaired synthetic and secretory activity of hyperplastic depots of adipose tissue. As a ...
Oliveras-Cañellas, Núria (Data de defensa: 2024-10-09)
ENG- The prevalence of obesity has increased dramatically in recent years and has reached epidemic proportions. Obesity is a chronic multifactorial disease associated with an abnormal accumulation of dysfunctional adipose ...
Perez-Serra, Alexandra (Data de defensa: 2024-10-18)
ENG- Atherosclerotic cardiovascular diseases are efficiently treated with statins. These medications can cause unwanted muscle problems in some patients, leading them to discontinue treatment. In this context, the ...
Rosell Díaz , Marisel (Data de defensa: 2024-10-07)
ENG- The global obesity epidemic represents a major threat to public health worldwide. Obesity is associated with many complications that reduce quality of life and longevity. Complications associated with obesity include ...
Queralt, Bernardo (Data de defensa: 2024-09-30)
ENG- Metastatic colorectal cancer (mCRC) remains a major medical challenge, particularly in the search for effective treatments such as epidermal growth factor receptor (EGFR)-targeted therapies. While mutations in the ...
Gómez-Vilarrubla, Ariadna (Data de defensa: 2024-07-24)
ENG- The increase in the prevalence of obesity worldwide over the past 50 years has led to obesity being considered the pandemic of the 21st century. Overweight and obesity are under scrutiny because the current pediatric ...
Poyatos Dorado, Paula (Data de defensa: 2024-07-08)
The endothelium, the lining of our blood vessels, plays a crucial role in controlling functions such as blood flow, clotting and inflammation. When it does not function properly, called endothelial dysfunction, it can lead ...
Iglesies-Grau, Josep (Data de defensa: 2024-06-21)
Background: Atherosclerotic cardiovascular disease (ASCVD) manifests silently as subclinical atherosclerosis before a clinical event. Disparities in ASCVD risk, particularly among underrepresented ethnic and racial groups, ...
Verdura Martínez, Sara (Data de defensa: 2024-06-07)
Non-small cell lung cancer (NSCLC) is a challenging disease to treat. Despite several decades of improved clinical progress, there is an unmet need to investigate how therapeutic resistance develops. In particular, managing ...
Gonzalez Montes, Yolanda (Data de defensa: 2024-04-12)
Multiple myeloma (MM) remains an incurable disease despite the incorporation of new therapies. The natural history of disease is of the relapse following treatments due to the re-emergence of the tumour from residual disease ...
Servitja Tormo, Ramon (Data de defensa: 2024-03-15)
Pain in the buttock region without lumbar pathology will lead us to focus the study on the region of the subgluteal space. This is defined as the deep gluteal syndrome. The deep gluteal syndrome is a condition with a very ...
Delisau-Puig, Olga (Data de defensa: 2023-12-15)
INTRODUCTION: Adrenal masses are one of the most common tumors, being incidentally diagnosed in 5% of patients undergoing imaging tests. Until the beginning of the 1990s, all adrenal surgical treatment was performed through ...
Fages Masmiquel, Ester (Data de defensa: 2023-09-14)
Dementia causes progressive cognitive impairment and inability to lead an independent life. Currently, there is no curative treatment for it, and thus primary prevention is essential. Age is the main risk factor for ...
Guzmán Heras, Lidia Elizabeth (Data de defensa: 2023-07-05)
The increase of elderly population in Spain is one of the most important challenges for their caregivers, healthcare professionals, and the society in general. The elderly population has the highest incidence rate of ...
Díaz Roldán, Ferran (Data de defensa: 2023-07-03)
Childhood obesity is one of the most important public health problems and is associated with cardiometabolic risk factors (CMR). Low-grade inflammation plays a prominent role in the development of cardiometabolic alterations ...
616.1 - Patologia del sistema circulatori, dels vasos sanguinis. Trastorns cardiovasculars (44)
616 - Patologia. Medicina clínica. Oncologia (21)
575 - Genètica general. Citogenètica general. Immunogenètica. Evolució. Filogènia (20)
616.8 - Neurologia. Neuropatologia. Sistema nerviós (17)
616.4 - Patologia del sistema limfàtic, òrgans hematopoètics, endocrins (15)